Phase II trial of hypofractionated intensity modulated radiotherapy in patients with low risk prostate cancer

Phase II trial of hypofractionated intensity modulated radiotherapy in patients with low risk prostate cancer - HiMRT-P2

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022570

Enrollment

Registered

2016-06-01

Start date

2015-11-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

radiotherapy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: pathological confirmation <=T3bN0M0 age>=20 y.o. PS=0 or 1 no history of pelvic irradiation normal general condition informed consent

Exclusion criteria

Exclusion criteria: no psychological disease no long term steroid prescription severe diabetes mellitus no active infection

Design outcomes

Primary

Measure	Time frame
Cumulative toxicity rate at 3 years after treatment	—

Countries

Japan

Contacts

Public Contacthiromichi ishiyama

kitasato university shool of medicine department of radiology and radiation oncology

hishiyam@kitasato-u.ac.jp042-778-8453

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026